This invention relates to transgenically produced human Antithrombin III (tgATIII). The human ATIII produced by the transgenic process of the present invention has a monosaccharide composition which comprises N-acetylgalactosamine (GalNAc) along with fucose, N-acetylglucosamine, galactose, mannose, and N-acetylneuraminic acid/N-glycolyneuraminic acid. The monosaccharide composition differs with that of plasma derived ATIII (phATIII). It has been found that tgATIII has an increased clearance rate when compared to phATIII.

 
Web www.patentalert.com

< Ornamental behavioral modification receptacle collar

< Method and installation for controlling the temperature in a controlled-climate chamber

> Methods to identify swine genetically resistant to F18 E. coli associated diseases

> Tangle free fishing pole

~ 00251